DEFINITIVE CONTRACT
Active75F40126C00181
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1.3M
obligated · signed 2 months ago
FIRM FIXED PRICE AWARD TOWARDS ML-POWERED, EFFICIENT AND ROBUST INFERENCE OF AVERAGE AND INDIVIDUAL TREATMENT EFFECTS FOR NOVEL CLINICAL TRIALS IN RARE DISEASES CONTRACTING OFFICER REPRESENTATIVE: DEBORAH ELLIOTT TELEPHONE: (240) 397-3022 DEBO
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2030
with all options
Loading status
Estimated start: Sep 29, 2029
DUKE UNIVERSITY
Contract 75F40126C00181
UEI
TP7EK8DZV6N5
Parent Company
DUKE UNIVERSITY
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$1,256,810
Base + Exercised Options
$1,256,810
Total Ceiling Value
$1,256,810
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.